STOCK TITAN

Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Evofem Biosciences (NASDAQ: EVFM) announced that CEO Saundra Pelletier will present at the Jefferies Virtual Healthcare Conference on June 4, 2021, at 10:30 a.m. ET. The presentation will be available via live webcast and archived for 30 days. The company focuses on developing products for women's sexual and reproductive health, including the hormone-free contraceptive Phexxi, launched in September 2020. Evofem is also evaluating the EVO100 candidate for preventing specific STIs in an ongoing Phase 3 clinical trial, EVOGUARD.

Positive
  • None.
Negative
  • None.

SAN DIEGO, June 1, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Saundra Pelletier, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:

Date: 

Friday, June 4, 2021

Time: 

10:30 a.m. ET (7:30 a.m. PT)

Webcast:   

https://wsw.com/webcast/jeff174/evfm/1851714 

 The presentation will be webcast live and archived for 30 days thereafter.

About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company launched its first FDA-approved commercial product, Phexxi® (lactic acid, citric acid and potassium bitartrate), in the United States in September 2020. The Company is evaluating lead product candidate EVO100 for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women in the ongoing Phase 3 clinical trial, 'EVOGUARD.' For more information, please visit evofem.com.

Phexxi® is a registered trademark of Evofem Biosciences, Inc.

Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-jefferies-virtual-healthcare-conference-2021-301302444.html

SOURCE Evofem Biosciences, Inc.

FAQ

When will Evofem Biosciences present at the Jefferies Virtual Healthcare Conference?

Evofem Biosciences will present on June 4, 2021, at 10:30 a.m. ET.

Who is presenting for Evofem Biosciences at the Jefferies Conference?

Saundra Pelletier, the CEO of Evofem Biosciences, will present.

How can I watch the Evofem Biosciences presentation?

The presentation will be available via live webcast at https://wsw.com/webcast/jeff174/evfm/1851714.

What is Evofem Biosciences known for?

Evofem Biosciences is known for developing innovative products for women's sexual and reproductive health, including the contraceptive Phexxi.

What ongoing clinical trial is Evofem Biosciences conducting?

Evofem is conducting the Phase 3 clinical trial named EVOGUARD, evaluating the EVO100 candidate for preventing STIs.

EVOFEM BIOSCIENCE INC

OTC:EVFM

EVFM Rankings

EVFM Latest News

EVFM Stock Data

1.00M
100.33M
0%
0.1%
10.98%
Biotechnology
Healthcare
Link
United States of America
San Diego